Atlas Trials

Advanced Hematological Disorders

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Advanced Hematological Disorders

RecordFirmDate
A Phase I, Two-part Study to Determine the Recommended Dose and Evaluate the Safety and Tolerability of a Novel Oral Arsenic Trioxide Formulation (ORH-2014) in Subjects With Advanced Hematological Disorders (NCT03048344)Orsenix LLC2016-12-02

Track Advanced Hematological Disorders automatically

Every clearance here is in the API, with alerts when new ones post.